Delivery Order SPE2DR25D1053-SPE2DR26FT779
- Not listed
- The Defense Logistics Agency awarded a $2,569.50 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mestinon 180 mg Timespan in units of 30, with completion scheduled for September 24, 2025. This firm fixed-price contract represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The Defense Logistics Agency awarded a $3,382.75 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,037.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 14, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,071.88 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in 30-tablet units. This contract, awarded on June 4, 2025, with completion targeted for June 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively issued and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $3,998.11 delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its Corporate Office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $9,466.34 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,667.30 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, for the supply of Mestinon 180 mg Timespan in units of 30 tablets. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025....
- The Defense Logistics Agency awarded a $5,900.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.36 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mestinon is a pharmaceutical product used in the treatment of myasthenia gravis and related...
- The Defense Logistics Agency awarded a delivery order valued at $2,496.72 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT779Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,947.10 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX and valued at $999,999,999.00 through December 2026). The award involved no set-aside designation and was competitively awarded. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds extensive federal contract experience supplying a broad range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Mestinon, a medication used in the treatment of myasthenia gravis and other neuromuscular conditions, exemplifies the company's role in supporting the Defense Health Agency and broader military healthcare programs through flexible and comprehensive contract vehicles designed to meet critical medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/10/25 |